Suppr超能文献

“地点”在解决艾滋病毒流行方面的重要性:来自赞比亚和南非 HPTN 071(PopART)集群随机对照试验的证据。

How 'place' matters for addressing the HIV epidemic: evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South Africa.

机构信息

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine (LSHTM), 15-17 Tavistock Place, London, WC1H 9SH, UK.

Zambart, School of Public Health, University of Zambia, Ridgeway Campus, P.O. Box 50697, Lusaka, Zambia.

出版信息

Trials. 2021 Apr 6;22(1):251. doi: 10.1186/s13063-021-05198-5.

Abstract

BACKGROUND

In a cluster-randomised trial (CRT) of combination HIV prevention (HPTN 071 (PopART)) in 12 Zambian communities and nine South African communities, carried out from 2012 to 2018, the intervention arm A that offered HIV treatment irrespective of CD4 count did not have a significant impact on population level HIV incidence. Intervention arm B, where HIV incidence was reduced by 30%, followed national guidelines that mid trial (2016) changed from starting HIV treatment according to a CD4 threshold of 500 to universal treatment. Using social science data on the 21 communities, we consider how place (community context) might have influenced the primary outcome result.

METHODS

A social science component documented longitudinally the context of trial communities. Data were collected through rapid qualitative assessment, interviews, group discussions and observations. There were a total of 1547 participants and 1127 observations. Using these data, literature and a series of qualitative analysis steps, we identified key community characteristics of relevance to HIV and triangulated these with HIV community level incidence.

RESULTS

Two interdependent social factors were relevant to communities' capability to manage HIV: stability/instability and responsiveness/resistance. Key components of stability were social cohesion; limited social change; a vibrant local economy; better health, education and recreational services; strong institutional presence; established middle-class residents; predictable mobility; and less poverty and crime. Key components of responsiveness were community leadership being open to change, stronger history of HIV initiatives, willingness to take up HIV services, less HIV-related stigma and a supported and enterprising youth population. There was a clear pattern of social factors across arms. Intervention arm A communities were notably more resistant and unstable. Intervention arm B communities were overall more responsive and stable.

CONCLUSIONS

In the specific case of the dissonant primary outcome results from the HPTN 071 (PopART) trial, the chance allocation of less stable, less responsive communities to arm A compared to arm B may explain some of the apparently smaller impact of the intervention in arm A. Stability and responsiveness appear to be two key social factors that may be relevant to secular trends in HIV incidence. We advocate for a systematic approach, using these factors as a framework, to community context in CRTs and monitoring HIV prevention efforts.

TRIAL REGISTRATION

ClinicalTrials.gov NCT01900977 . Registered on July 17, 2013.

摘要

背景

在 2012 年至 2018 年期间,在 12 个赞比亚社区和 9 个南非社区进行了一项针对艾滋病毒综合预防(HPTN 071(PopART))的集群随机试验(CRT),结果显示,提供无论 CD4 计数如何均可获得艾滋病毒治疗的干预组 A 并未对人群艾滋病毒发病率产生显著影响。干预组 B 降低了 30%的艾滋病毒发病率,该组遵循国家指南,于试验中期(2016 年)将艾滋病毒治疗的启动标准从 500 的 CD4 阈值更改为普遍治疗。利用针对 21 个社区的社会科学数据,我们考虑了地点(社区背景)如何影响主要结局结果。

方法

社会科学部分对试验社区的背景进行了纵向记录。数据通过快速定性评估、访谈、小组讨论和观察收集。共有 1547 名参与者和 1127 次观察。利用这些数据、文献以及一系列定性分析步骤,我们确定了与艾滋病毒相关的关键社区特征,并将这些特征与社区层面的艾滋病毒发病率进行了三角剖分。

结果

两个相互依存的社会因素与社区管理艾滋病毒的能力相关:稳定性/不稳定性和响应能力/抵抗力。稳定性的关键组成部分包括社会凝聚力;社会变化有限;充满活力的当地经济;更好的健康、教育和娱乐服务;强大的机构存在;有固定收入的中产阶级居民;可预测的流动性;贫困和犯罪率较低。响应能力的关键组成部分包括社区领导层愿意接受变革、更强的艾滋病毒举措历史、愿意接受艾滋病毒服务、较少的艾滋病毒相关耻辱感以及得到支持和有进取心的青年人群。这两个因素在各个干预组中都存在明显的模式。干预组 A 的社区明显更具抵抗力和不稳定性。干预组 B 的社区总体上更具响应能力和稳定性。

结论

在 HPTN 071(PopART)试验明显不一致的主要结局结果的特殊情况下,与干预组 B 相比,机会分配给不那么稳定、不那么响应的社区的可能性较小,这可能部分解释了干预组 A 的干预效果较小。稳定性和响应能力似乎是与艾滋病毒发病率的长期趋势相关的两个关键社会因素。我们主张采用一种系统的方法,将这些因素作为框架,用于 CRT 中的社区背景,并监测艾滋病毒预防工作。

试验注册

ClinicalTrials.gov NCT01900977。于 2013 年 7 月 17 日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c6/8025534/3bd76af6927a/13063_2021_5198_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验